Source: Author: Shannon Molloy


A Sydney doctor claims a head lice treatment that costs $2 could be a coronavirus cure and should be given to vulnerable patients now.

A renowned Sydney doctor is urging health authorities to give vulnerable people infected with coronavirus a cheap and freely available drug that he believes is an effective “cure”.

Frontline medical workers should also be given it preventively to lower risk and in light of the large number who have contracted COVID-19 in Victoria, he argues.

Professor Thomas Borody, a gastroenterologist credited with developing a world-first cure for peptic ulcers, saving countless lives, has stepped up his advocacy for what he believes is the “answer to Australia’s COVID-19 crisis”.

Taken together, Ivermectin – a treatment for head lice that costs as little as $2 – combined with zinc and the antibiotic Doxycycline, could be a “potential lifesaver right now”, Professor Borody said.

“These three medications are already approved,” he said.

“They do not need preclinical or clinical trials nor additional (Therapeutic Goods Administration) approvals unless the aim is to combine in a single capsule, for example.

“Patient treatment programs have been done in the US and elsewhere which indicate it can work within four to six days.”

Ivermectin was authorised as a treatment for patients with mild or suspected COVID-19 in Colombia and Peru. Picture: AFPSource:AFP
Professor Thomas Borody is urging health authorities to adopt his proposed tri-treatment, using Ivermectin, to treat COVID-19 patients in Australia. Picture: SuppliedSource:Supplied

A handful of South American countries have deployed Ivermectin as both a treatment and preventive measure after early laboratory research indicated it may eliminate COVID-19.

Professor Borody believes the combination of three approved ‘off the shelf’ drugs could be a “cure”.

Concerns have been raised about some of the Ivermectin trials, with warnings that rushing it to human use might do more harm than good in coronavirus cases.

That hasn’t stopped Professor Borody writing to both the Federal and Victorian Government urging authorities to heed his advice.

The Daily Telegraph today reported that those pleas have fallen on deaf ears and described Professor Borody as having “invented an effective, cheap, readily available treatment for COVID-19 and his own country ignored him”.

“I wrote to the federal and state governments,” he told the newspaper.

“I wasn’t even responded to … It got to a certain level of the fortress, but I don’t think it got to the decision-makers. You can see how frustrating it is, whereas a big state of India says ‘let’s use it’.”

Related: Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

Use of Ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt : A randomised clinical trial

HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Hydroxychloroquine & Covid-19: India and France, a cruel comparison

Use of ivermectin to treat coronavirus patients approved in Slovakia

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »